Aug 13, 2020
Hoth Therapeutic Announces That It Has Submitted its Request to Australia Ethics Board to Begin Clinical Trial of BioLexa for Atopic Dermatitis
Aug 12, 2020
LASEROPTEK Co. Ltd., Announces U.S. Launch of PALLAS, First-of-its-Kind Solid State UVB Medical Dermatology Laser
Jun 19, 2020
FDA approves new Dupixent® (dupilumab) pre-filled pen designed to support more convenient self-administration
Jun 19, 2020
Dupixent® (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
Jun 12, 2020
Lilly and Dermira Present New Lebrikizumab Phase 2b Clinical Data Showing Patients with Atopic Dermatitis Had Clinically Meaningful Improvements in Itch, Sleep and Quality of Life
Jun 12, 2020
Existing and Upcoming Therapies for Most Common Allergic, Infectious Diseases Including COVID-19
May 26, 2020
FDA Approves Dupixent® (dupilumab) as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis
May 26, 2020
Arena Completes Full Enrollment of Etrasimod Phase 2 ADVISE Trial for Atopic Dermatitis, Provides Program Updates
May 08, 2020
NEA Announces 2020 Eczema Research Grant Cycle Opening
Apr 16, 2020
Crutchfield Dermatology Notes a Rise in Hand Eczema Due to Coronavirus Handwashing
Apr 03, 2020
Dupixent® (dupilumab) Phase 3 Data at Revolutionizing Atopic Dermatitis Conference Show Significant Improvement in Severe Atopic Dermatitis for Children Aged 6 to 11 Years
Mar 26, 2020
Medimetriks Announces that Otsuka Achieved Positive Top-Line Phase 3 Results for MM36 (difamilast) in Japanese Adult and Pediatric Atopic Dermatitis Patients
Mar 24, 2020
Global Chronic Hand Eczema (CHE) Markets, Epidemiology, Drugs, Pipeline and Forecast to 2030
Mar 16, 2020
Diamond Equity Research Publishes Report Valuing HOTH Common Stock at $7.00 Per Share
Mar 12, 2020
American Skin Association Announces 13 New Grants for Skin Cancer and Disease Research in 2020
Mar 05, 2020
NEA and PeDRA Announce 2020 Childhood Eczema Challenge Grant
Feb 25, 2020
Vanda Reports results from the EPIONE study of Tradipitant in the treatment of Pruritus in Atopic Dermatitis
Feb 19, 2020
Hoth Therapeutics Receives Notice of Allowance from European Patent Office
Feb 03, 2020
Atopic Dermatitis (AD) Industry Outlook to 2024 - Elaborate Pipelines of Pharmaceutical Companies Spurs Growth
Jan 29, 2020
Angie Seelal, R-PAC with Advanced Dermatology PC, Shares Tips on Managing Atopic Dermatitis